Leprosy: diagnostic and control challenges for a worldwide disease
- 7 May 2008
- journal article
- review article
- Published by Springer Science and Business Media LLC in Archiv für dermatologische Forschung
- Vol. 300 (6), 269-290
- https://doi.org/10.1007/s00403-008-0857-y
Abstract
Leprosy is a curable disease with well-defined etiology, but lacks better diagnostic tools, preventive and therapeutic strategies. The continued application of the Ridley–Jopling clinical classification that recognizes the natural diversity of the immune response has provided the basis for understanding leprosy, and this review proposes its implementation in all Reference Centers in order to standardize the diagnostic resources, aiming at the improvement of the disease control. Due to the broad bioepidemiological aspects of infection its eradication is difficult, and proper diagnosis of the disease and the correct clinical classification are required to ensure proper treatment. Tools and markers for diagnosis and prognosis, and the novel use of nanotechnology, as well as strategies for disease control and monitoring populations at higher risk are still continuous challenges, which will be specifically reviewed with additional insights. The use of the current diagnostic tools, such as ELISA and PCR has a very limited approach for leprosy that has been considered as a marginal disease; therefore, the current diagnostic tools must be applied extensively in the routine to accumulate clinical experience in order to improve their precise application, like what has been done in many other infectious diseases. Since a vaccine for leprosy presents an unpredictable future, the proposed chemoprophylaxis of contacts (healthy carriers and/or with subclinical infection) must also be employed in referral centers of endemic countries not only to evaluate its efficacy, but also because of the favorable cost–benefit ratio, given that there is no other available approach, besides the multi-drug therapy of patients. This strategy should readily be applied as a public health policy, and may lead to a substantial breakage of the transmission chain aiming a world without leprosy.This publication has 152 references indexed in Scilit:
- Rational Combination of Peptides Derived from Different Mycobacterium leprae Proteins Improves Sensitivity for Immunodiagnosis of M. leprae InfectionClinical and Vaccine Immunology, 2008
- Risk and Protective Factors for Leprosy Development Determined by Epidemiological Surveillance of Household ContactsClinical and Vaccine Immunology, 2008
- A simplified reverse transcriptase PCR for rapid detection ofMycobacterium lepraein skin specimensFEMS Immunology & Medical Microbiology, 2006
- Use of Protein Microarrays To Define the Humoral Immune Response in Leprosy Patients and Identification of Disease-State-Specific Antigenic ProfilesInfection and Immunity, 2006
- Evaluation of Real-Time and Conventional PCR Targeting Complex 85 Genes for Detection of Mycobacterium leprae DNA in Skin Biopsy Samples from Patients Diagnosed with LeprosyJournal of Clinical Microbiology, 2006
- The Continuing Challenges of LeprosyClinical Microbiology Reviews, 2006
- Prospective Study of Serological Conversion as a Risk Factor for Development of Leprosy among Household ContactsClinical and Vaccine Immunology, 2004
- Detection and quantification of Mycobacterium leprae in tissue samples by real-time PCRMedical Microbiology and Immunology, 2003
- Detection of Phenolic Glycolipid I of Mycobacterium leprae in Sera from Leprosy Patients before and after Start of Multidrug TherapyClinical and Diagnostic Laboratory Immunology, 2001
- Selection of a gyrA Mutant of Mycobacterium tuberculosis Resistant to Fluoroquinolones during Treatment with OfloxacinThe Journal of Infectious Diseases, 1994